PCK Share Price Performance
AU$0.057
0.03 (83.88%)
Price AU$0.057
Share PriceAU$0.057
PainChek Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
PCK Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
PainChek Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.0037
- 29.67%
- -228.18%
- 0%
About PCK
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
